Advertisement
Cardiovascular
Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

New Biotech Company Launches After Discovery

July 30, 2012 11:03 am | by Casandra Andrews, Press-Register | News | Comments

The business, Exscien -- which in Latin means 'for science' -- was recently awarded a grant by the National Institutes of Health to support the development of a new drug aimed at preventing and reversing acute lung injury.

Roper Industries Buys Sunquest for $1.42B

July 30, 2012 10:51 am | by AP | News | Comments

Medical and industrial equipment maker Roper Industries is buying hospital software company Sunquest Information Systems for approximately $1.42 billion.

Adult Stem Cells From Liposuction Used to Create Blood Vessels in the Lab

July 26, 2012 11:39 am | News | Comments

Adult stem cells extracted during liposuction can be used to grow healthy new small-diameter blood vessels for use in heart bypass surgery and other procedures, according to new research presented at the American Heart Association's Basic Cardiovascular Sciences 2012 Scientific Sessions.

Advertisement

Applying Tech: Implantables

July 25, 2012 2:58 pm | by Mark Russell, Tricia Rodewald, and Michael Klayman | Pro-Dex, Bal Seal Engineering, Inc. | Articles | Comments

How are you influencing implantable devices?

1st SynCardia Total Artificial Heart Implant Performed in New England

July 12, 2012 11:27 am | News | Comments

SynCardia Systems, Inc., manufacturer of the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Harvard-affiliated Brigham and Women’s Hospital in Boston has performed New England’s first implant of the SynCardia temporary Total Artificial Heart.

FDA Clears Cook Medical’s Evolution Colonic Controlled-Release Stent

July 9, 2012 10:58 am | News | Comments

The U.S. Food and Drug Administration (FDA) has granted Cook Medical 510(k) clearance for the Evolution® Colonic Controlled-Release Stent, Cook announced today. The new stent expands Cook's line of Evolution controlled-release stents...

FSS lands extended CE Mark for FlexStent | Regulatory Roundup

June 29, 2012 2:21 pm | by Mass Device | News | Comments

Flexible Stenting Solutions touts CE Mark approval for additional sizes of its FlexStent self-expanding iliac stents.  FSS touts CE Mark win for new self-expanding stent sizes News Well, 510(k), CE Mark, Food & Drug Administration (FDA), Regulatory Roundup, Regulatory/Complianceread more

Applying Tech: Cardiovascular

June 27, 2012 5:38 pm | Articles | Comments

How are you influencing cardiovascular devices?

Advertisement

FDA approves SonixGPS needle guidance technology for vascular access procedures

June 26, 2012 5:49 am | News | Comments

Ultrasonix Medical Corporation has received approval from the US Food and Drug Administration for its SonixGPS technology for Vascular Access procedures.

Pitt Develops Biodegradable Artery Graft to Enhance Bypass Surgeries

June 25, 2012 10:58 am | News | Comments

With the University of Pittsburgh’s development of a cell-free, biodegradable artery graft comes a potentially transformative change in coronary artery bypass surgeries: Within 90 days after surgery, the patient will have a regenerated artery...

Cook Medical Sponsors First Clinical Study to Examine New Endovascular Technique

June 25, 2012 10:30 am | News | Comments

Clinical investigators are for the first time examining the retrograde tibiopedal interventional approach, an endovascular technique that has the potential to reduce the rate of leg amputations by as much as 50 percent in patients with critical limb ischemia...

Discovery of ‘Master Molecule’ Could Improve Stem Cell Treatment for Heart Attacks

June 25, 2012 7:34 am | News | Comments

Johns Hopkins researchers have discovered that a single protein molecule may hold the key to turning cardiac stem cells into blood vessels or muscle tissue, a finding that may lead to better ways to treat heart attack patients.

Penumbra Inc. Launches the New MAX System Reperfusion Catheters for Acute Ischemic Stroke Patients

June 19, 2012 6:03 am | News | Comments

The Penumbra System® family of aspiration thrombectomy devices now includes the MAX System of Reperfusion Catheters for removal of clots in patients experiencing acute ischemic stroke. The MAX System neuro-interventional devices offer a fast, simplified...

Advertisement

CardiAQ Valve Technologies Reports Cardiovascular Medicine Milestone: First-in-Human Nonsurgical Percutaneous Implantation of a Bioprosthetic Mitral Heart Valve

June 15, 2012 6:01 am | News | Comments

CardiAQ Valve Technologies (CardiAQ), which has developed the world’s first self-conforming and self-anchoring technology for nonsurgical Transcatheter Mitral Valve Implantation (TMVI), today announced that the Company has achieved a cardiovascular medicine milestone...

STENTYS Starts Clinical Trial to Broaden Portfolio with New Drug-Eluting Stent

June 15, 2012 5:56 am | News | Comments

STENTYS S.A. (STNT.PA), a medical technology company commercializing the world's first and only Self-Apposing® Stent to treat Acute Myocardial Infarction (AMI), announced today that it has enrolled the first patient in its ‘APPOSITION IV’ clinical study...

Tiny Robots Mend Broken Hearts

June 8, 2012 12:35 am | by Massachusetts Institute of Technology | News | Comments

Millimeter-scale devices could give surgeons the ability to operate on beating hearts.

Medtronic Launches Endurant II AAA Stent Graft System in U.S.

June 7, 2012 7:55 am | News | Comments

Medtronic, Inc. has announced the U.S. launch of the Endurant® II AAA Stent Graft System, which recently received approval from the U.S. Food and Drug Administration (FDA) for the minimally invasive treatment of abdominal aortic aneurysms through endovascular repair...

Welch Allyn Donates Devices to Program that Helps Raise Awareness of Hypertension Among African Americans

June 6, 2012 6:15 am | News | Comments

Welch Allyn, a leading global provider of frontline medical products and solutions, today announced it has donated 50 Spot Vital Signs® devices to the American Methodist Episcopal Church (AMEC) Connectional Health Commission’s program, “Manage BP with AMECHealth.”

Vena cava filters do not lower mortality rate in most embolism cases

June 1, 2012 6:41 am | News | Comments

A filter used to block clots from passing from the veins in the legs to the arteries of the lung does not improve mortality rates for most patients suffering a pulmonary embolism. However, if a patient is unstable – in shock or requires a ventilator – filters can save lives.

Custom Laser Job Shop Services

May 18, 2012 10:43 am | Laserage Technology Corporation | Product Releases | Comments

The stent material, cutting techniques, finishing techniques, and inspection techniques are integral to a quality medical stent. Careful customization is required with these processes...

A North American first at the Montreal Heart Institute

May 18, 2012 7:10 am | News | Comments

The surgical team at the Montreal Heart Institute (MHI) achieved a North American surgical milestone on May 1st with a sutureless aortic valve replacement through a thoracic incision just five centimetres long. The two patients in their seventies who underwent this innovative...

PROMUS Element Stent Demonstrates Excellent Long-Term Safety and Effectiveness in PLATINUM Small Vessel Study

May 18, 2012 6:55 am | News | Comments

Boston Scientific Corporation announces two-year results from the PLATINUM Small Vessel study, demonstrating excellent safety and effectiveness outcomes for the 2.25 mm PROMUS Element™ Everolimus-Eluting Platinum Chromium (PtCr) Stent System...

BiO2 Medical Granted CE Mark for the Angel Catheter, the First IVC Filter with a Prophylactic Use Indication

May 15, 2012 12:23 pm | News | Comments

BiO2 Medical, Inc. a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colorado, announced today that it has received CE Mark approval for the Angel™ Catheter, a Nitinol Inferior Vena Cava...

Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe

May 15, 2012 11:57 am | News | Comments

As EuroPCR 2012 gets under way today, Medtronic, Inc. announced that the Resolute Integrity Coronary Stent System has received European regulatory approval for several new indications, making it the drug-eluting stent (DES) with the broadest range of approved indications...

Boston Scientific Announces Positive Data From Lotus Transcatheter Aortic Valve Trial

May 15, 2012 11:43 am | News | Comments

Boston Scientific Corporation announces results from the REPRISE I feasibility trial, which evaluated the acute safety of the Lotus™ Aortic Valve System in patients with severe aortic valve disease.  The Lotus Aortic Valve System is the first transcatheter aortic valve replacement...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading